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http://dx.doiabstractBACKGROUND: This study examined the risk of adverse maternal and neonatal outcomes, especially cerebral palsy
and intellectual disability, in pregnant women with and without chronic kidney disease and their children.
METHOD: In total, 156 pregnancies involving 139 women with chronic kidney disease who were treated at our
center between 2001 and 2010 were identiﬁed. We also selected 3067 womenwithout chronic kidney disease who
delivered their infants without suffering any medical complications during the same period as control groups.
Long-term neonatal prognosis was assessed based on the frequencies of cerebral palsy and/or intellectual
disability. RESULTS: The pregnant women had the following types of chronic kidney disease: immunoglobulin A
nephropathy (n ¼ 54), glomerulonephritis (n ¼ 17), chronic renal failure (n ¼ 16), nephrotic syndrome (n ¼ 12),
nephritis (n ¼ 11), diabetic nephropathy (n ¼ 10), congenital malformations and deformations (n ¼ 10), purpura
nephritis (n ¼ 7), and others (n ¼ 19). Of the children who were born to mothers with chronic kidney disease, one
developed cerebral palsy, and another developed cerebral palsy with intellectual disability. Seven of the children
who were born to mothers without chronic kidney disease developed cerebral palsy. The posterior probability of
these conditions was 0.01900 and 0.002610 in the children born to mothers with and without chronic kidney
disease, respectively. A primiparous mother (odds ratio [OR]: 4.07, 95% conﬁdence interval [CI]): 2.78 to 5.95),
preeclampsia (OR: 6.44, 95% CI: 3.92 to 10.59), grade 1 to 4 intraventricular hemorrhaging (OR: 7.71, 95% CI: 2.05 to
28.92), and an Apgar score of less than 7 at ﬁve minutes (OR: 0.51, 95% CI: 0.27 to 0.96) were found to inﬂuence the
risk of cerebral palsy and/or intellectual disability in children born to women with chronic kidney disease.
CONCLUSION: We found that the incidence of cerebral palsy and/or intellectual disability is 7.2-fold higher in
children born to womenwith chronic kidney disease than in those born to womenwithout chronic kidney disease.
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Pregnant women with chronic kidney disease are at
greater risk of maternal and fetal complications.1-6 For
example, Kendrick et al.1 concluded that infants born toory:
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.org/10.1016/j.pediatrneurol.2016.03.007women with kidney disease are at a 71% greater risk of
being admitted to the neonatal intensive care unit or death
than infants born to women without kidney disease (odds
ratio [OR]: 1.71; 95% conﬁdence interval [CI]: 1.17 to 2.51)
and that women with chronic kidney disease are at a two-
fold higher risk of delivering low birth weight infants (OR:
2.38; 95% CI: 1.64 to 3.44). Moreover, Fink et al.4 concluded
that womenwith renal diseasewere also at increased risk of
delivering infants that were small for their gestational age
(SGA; OR: 5.3, 95% CI: 2.8 to 10.0) and/or had ﬁve-minute
Apgar scores of less than 7 (OR: 3.9, 95% CI: 1.1 to 14.6).
Although several reports have indicated that pregnant
F. Tsuchiyama et al. / Pediatric Neurology 73 (2017) 71e7772women with chronic kidney disease are at increased risk of
adverse maternal and fetal outcomes, the long-term prog-
nosis of neonates born to such women including their risk
of cerebral palsy and intellectual disability is unclear.1-6
We performed a retrospective cohort study examining
the risk of adverse maternal and neonatal outcomes, espe-
cially cerebral palsy and intellectual disability, in pregnant
women with and without chronic kidney disease and their
children.Materials and Methods
This study was approved by the ethics committee of Tokyo Women’s
Medical University. The medical records of the mothers and infants were
reviewed. In this study, 156 singleton pregnancies involving 139 women
with chronic kidney disease whose infants were delivered between 22
and 41 weeks of gestation at the Maternal and Perinatal Center,
Maternal-Fetal Division, Tokyo Women’s Medical University Hospital,
between January 1, 2001, and December 31, 2010, were examined.
Chronic kidney disease was diagnosed based on the Kidney Disease
Outcomes Quality Initiative deﬁnition of chronic kidney disease (the
presence of kidney lesions or a glomerular ﬁltration rate of less than
90 mL/min/1.73 m2).7 We also randomly selected 3067 women without
chronic kidney disease who delivered their infants without suffering any
medical complications during the same period as control groups. All
pregnancies involving multiple pregnancies, fetal anomalies, intrauter-
ine fetal death, or preconception dialysis were excluded from this study.
Gestational age was determined based on the last menstrual period
and standard obstetric ultrasound examinations. All the patients had
been permitted to continue their pregnancies by obstetricians and were
managed in collaboration with nephrologists.
Threatened preterm labor was deﬁned as progressive dilatation of
the cervix combined with regular uterine contractions that occurred
between 22 and 36 weeks of gestation.8 Premature rupture of mem-
branes (PROM) was deﬁned as the observation of amniotic ﬂuid pooling
in the vagina, ferning, or a reduction in the volume of amniotic ﬂuid on
ultrasound,8 or a positive result during testing with Check PROM (an
insulin-like growth factor binding protein-1 reagent). According to the
criteria of the National High Blood Pressure Education Program, hyper-
tensive disorders in pregnancy can be classiﬁed into chronic hyperten-
sion, pregnancy-induced hypertension, preeclampsia, and superimposed
preeclampsia.9 Womenwhose blood pressure reached 140/90 mm Hg or
more after the 20th week of gestation, but who did not exhibit pro-
teinuria, were diagnosed with pregnancy-induced hypertension.10
Preeclampsia was deﬁned as systemic hypertension exceeding 140/
90 mm Hg accompanied by proteinuria after the 20th week of gesta-
tion.11 Proteinuria was deﬁned as a 24-hour urinary protein level of
300 mg or a score of 1 during dipstick tests of random urine sam-
ples.11 Chorioamnionitis was clinically diagnosed based on the patients’
medical records. The clinical ﬁndings of chorioamnionitis were consid-
ered to include maternal fever (greater than 100.4F) and at least one of
uterine fundal tenderness, maternal tachycardia (greater than 100 beats/
min), maternal leukocytosis, and foul-smelling amniotic ﬂuid.12,13
Hospitalization was considered necessary for hypertension,
pregnancy-induced hypertension, worsening renal dysfunction, new
onset proteinuria, markedly worsening proteinuria, threatened preterm
labor, PROM, and intrauterine growth restriction (IUGR).
Regarding the fetal assessments performed during the patients’
hospitalization, the initial ultrasound scan was used to estimate fetal
weight and amniotic ﬂuid volume, and then further ultrasound evalua-
tions were performed every seven days and used to evaluate fetal
growth. Nonstress testing was performed daily, and biophysical proﬁles
were obtained when necessary.
Delivery was allowed to occur after the onset of active labor in the
presence of maternal indications, such as signiﬁcant renal dysfunction,
the onset of pregnancy-induced hypertension, or clinical chorioamnio-
nitis, and fetal indications such as growth arrest, a nonreassuring fetal
status, and a gestational age greater than 37 weeks. Caesarean sections
were performed in patients who had previously undergone Caesareansections and patients who did not respond to induction, a nonreassuring
fetal status, fetal malpresentation, or maternal indications. Short-term
neonatal prognosis was evaluated based on the following conditions:
premature birth (less than 37 weeks of gestation), SGA (below the tenth
birth weight percentile for the infant’s gestational age), neonatal death
(within 28 days of birth), and infantile death after discharge. Long-term
neonatal prognosis was assessed based on the incidence of cerebral palsy
and/or intellectual disability (an intelligence quotient or development
quotient of less than 70).14 Cerebral palsy was deﬁned as a nonpro-
gressive, nontransient central nervous system disorder that is charac-
terized by abnormal muscle tone in at least one extremity and abnormal
control of movement and posture.15 In addition to meeting the above
criteria, the infants had to be aged at least 2 years at the most recent
diagnosis to be deﬁnitively diagnosed with cerebral palsy. In patients
with suspected cerebral palsy, the infants’ physical ﬁndings were
reviewed by a developmental pediatrician. In addition, a developmental
quotient of less than 70 was interpreted as representing signiﬁcantly
delayed performance (intellectual disability).15
The infants were assessed for periventricular echodensity, intraven-
tricular hemorrhaging (IVH), and periventricular leukomalacia (PVL).
Periventricular echodensity was deﬁned as conﬂuent areas of increased
echogenicity compared with the echogenicity of the choroid plexus. IVH
was detected using cranial ultrasonography and was graded from 1 to 4
according to the classiﬁcation developed by Papile et al.16 PVL was
diagnosed based on the presence of echodense or echolucent areas in the
periventricular regions on coronal and sagittal views.17Statistical analysis
The results are expressed as mean  standard deviation values. Sta-
tistical analyses were performed using the chi-square test, Fisher exact
probability test, theManneWhitneyU test, the Student t test, or multiple
regression analysis (SAS software, version 9.13, SAS Institute Inc). The
signiﬁcance of the differences between the with chronic kidney disease
and without chronic kidney disease groups were assessed using the
Student t test or ManneWhitney U test for continuous variables and the
chi-square test or Fisher exact probability test for categorical variables. P
values of <0.05 were considered to be signiﬁcant. OR and 95% CI were
calculated to estimate how each factor inﬂuenced the relative risk of
cerebral palsy and/or intellectual disability in the children of women
with chronic kidney disease. The results were compared using both
univariate and multivariate analyses, whereas logistic regression models
were used to assess the inﬂuence of confounding factors. Posterior
probabilities and highest probability densities were calculated to esti-
mate the frequency of cerebral palsy and/or intellectual disability in the
children of women with chronic kidney disease and the children of
women without chronic kidney disease.Results
The pregnant women exhibited the following types of
chronic kidney disease: immunoglobulin A nephropathy
(n ¼ 54), glomerulonephritis (n ¼ 17), chronic renal failure
(n ¼ 16), nephrotic syndrome (n ¼ 12), nephritis (n ¼ 11),
diabetic nephropathy (n ¼ 10), congenital malformations
and deformations (n ¼ 10), purpura nephritis (n ¼ 7), and
others (n ¼ 19).
The maternal and neonatal outcomes involving pregnant
women with and without chronic kidney disease are
described in Table 1. The pregnant women with chronic
kidney disease exhibited signiﬁcantly higher frequencies of
primipara (74.3%), preeclampsia (17.9%), preterm delivery
(34.6%), and Caesarean sections (46.1%) than the pregnant
women without chronic kidney disease (P < 0.001). There
was no difference in the frequency of abruptio placentae,
placenta previa, PROM, or chorioamnionitis between the
two groups. The mean gestational age at delivery of the
TABLE 1.
Maternal and Neonatal Outcomes of Pregnancies Involving Women With and Without Chronic Kidney Disease (CKD)
Variables CKD (n ¼ 156) No CKD (n ¼ 3,067) P Value
Primipara (n) 116 1885 <0.001
Maternal age (yr) 32.5  4.8 32.3  4.8 0.614
Obstetric complications (n)
Threatened premature labor (n) 28 555 0.963
Preeclampsia (n) 28 90 <0.001
Abruptio placentae (n) 0 7 0.55
Placenta previa (n) 2 35 0.872
Preterm premature rupture of membranes (n) 5 146 0.482
Chorioamnionitis (n) 0 11 0.934
Mean gestational age at delivery (wk) 36.3  4.0 37.6  3.3 <0.001
Preterm delivery (<37 wk ; n) 54 597 <0.001
Nonreassuring fetal status (n) 16 259 0.52
Mode of delivery: Caesarean section (n) 72 908 <0.001
Maternal death (n) 0 0 1
Neonatal outcomes
pH of umbilical artery <7.0 (n) 0 7 0.55
Mean birth weight (g) 2459.7  777.7 2765.0  656.1 <0.001
Apgar score <7 at 1 min (n) 18 246 0.158
Apgar score <7 at 5 min (n) 7 79 0.234
Small for gestational age (n) 15 139 0.027
Male sex (n) 92 1582 0.085
Neonatal outcomes
Periventricular leukomalacia 2 8 0.134
Grade 1-4 intraventricular hemorrhaging 4 13 0.002
Neonatal death (n) 1 0 0.035
Cerebral palsy and/or intellectual disability (n) 2 7 0.098
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disease exhibited was 36.3  4.0 weeks (range: 23 to 41)
and 37.6  3.3 weeks (range: 22 to 42), respectively
(P < 0.001).
Regarding neonatal outcomes, the mean birth weights of
the children delivered by the women with and without
chronic kidney disease were 2459.7  777.7 g and
2765.0  656.1 g, respectively (P < 0.001). SGA (9.6%) was
more common among the children born to the womenwith
chronic kidney disease than in those delivered by the
women without chronic kidney disease (P ¼ 0.027). IVH
(2.5%) occurred more frequently in the infants born to the
women with chronic kidney disease than in those born to
the women without chronic kidney disease (P ¼ 0.002).
Among the 156 children born towomenwith chronic kidney
disease, one childwas subsequently diagnosedwith cerebral
palsy, and another was diagnosed with cerebral palsy and
intellectual disability (Table 2). On the other hand, seven of
the children that were born to women without chronic
kidney disease subsequently developed cerebral palsy alone,
and none of the children that were born to women without
chronic kidney disease were diagnosed with intellectual
disability (Table 2). There was no difference in the incidence
of cerebral palsy and/or intellectual disability between the
two groups. There was one neonatal death (0.6%) among the
pregnancies involving women with chronic kidney disease.
The latter neonate was born at 30 weeks’ gestation and
exhibited a birth weight of 1284 g and Apgar scores of 4 and
7 at one and ﬁve minutes, respectively. She subsequently
died of neonatal toxic shock syndrome-like exanthematous
disease on the 14th day after birth.
The clinical characteristics of the infants that developed
cerebral palsy and/or intellectual disability are described inTable 2. Two of the women whose children developed ce-
rebral palsy and/or intellectual disability had chronic kid-
ney disease, one had chronic glomerulonephritis, and the
other had immunoglobulin A nephropathy. In the former
case, a 1,050 g appropriate for gestational age male was
born at 28 weeks of gestation to a 32-year-old primiparous
female who had experienced a single episode of PROM on
the day of delivery. The infant’s Apgar score was 7 at
one minute and 8 at ﬁve minutes. An ultrasound exami-
nation of the infant’s brain performed on the 29th day of life
detected cystic PVL. He was diagnosed with bilateral spastic
paralysis and intellectual disability at age of three years.
In the latter case, a 1,156 g appropriate for gestational age
male was born at 28 weeks of gestation to a 38-year-old
multiparous woman who had experienced a single episode
of severe preeclampsia on the day of delivery. An ultrasound
examination of the infant’s brain performed on the day after
birth detected grade 4 IVH, and the infant manifested sei-
zures on the second day after delivery. He was diagnosed
with cerebral palsy at age three years and is now
seven years old.
In patient number 7, which involved a woman without
chronic kidney disease, labor and delivery were monitored
closely, and there were no signs of intrapartum asphyxia.
The infant exhibited signs of apnea at ﬁve hours after de-
livery and was admitted to the neonatal intensive care unit.
An ultrasound examination of his brain performed on the
second day after birth detected grade 2 periventricular
echogenicity, and he subsequently manifested seizures. He
is now six years old and has developed cerebral palsy.
The posterior probabilities and highest probability den-
sities of cerebral palsy and/or intellectual disability in the
children of womenwith andwithout chronic kidney disease
TABLE 2.
Cases of CP/Intellectual Disability Involving the Children of Pregnant Women With and Without CKD
Number Variables Renal Disease Obstetric
Complications
and Reason for
Termination
Delivery
Mode
Gestational
Age at
Delivery
(wk)
Birth
Weight
(g)
SGA Sex Apgar Score
1 and 5 min
pH of
Umbilical
Artery
Diagnosis
and Prognosis
With CKD
1 CP þ ID Chronic
glomerulonephritis
Preterm PROM
Renal dysfunction
Vaginal
delivery
28 1050 (-) Male 7 and 8 7.363 Cystic PVL
2 CP Immunoglobulin
A nephropathy
Severe PIH CS 28 1156 (-) Male 7 and 8 7.225 Grade 4 IVH
Neonatal
seizures
Without CKD
1 CP None Prolapsed fetal
membranes
Threatened
premature labor
Vaginal
delivery
23 553 (-) Female 5 and 6 Unknown Grade 3 IVH
2 CP None Prolapsed fetal
membranes
Threatened
premature labor
CS 24 803 (-) Male 2 and 5 7.407 IVH Retinopathy
of prematurity
3 CP None Threatened
premature labor
CS 25 668 (-) Female 9 and 9 7.361 IVH
4 CP None Placenta previa
Preterm PROM
CS 28 1412 (-) Female 6 and 8 7.234 Grade 3 PVE
5 CP None Placenta previa CS 30 1472 (-) Male 5 and 9 7.317 Cystic PVL
6 CP None Placenta previa CS 30 1542 (-) Male 2 and 5 7.34 PVL
7 CP None Onset of labor Vaginal
delivery
39 2998 (-) Male 8 and 9 7.339 Grade 2 PVE
Neonatal
seizures
Abbreviations:
CKD ¼ chronic kidney disease
CP ¼ cerebral palsy
CS ¼ Caesarean section
ID ¼ intellectual disability
IVH ¼ intraventricular hemorrhaging
PIH ¼ pregnancy-induced hypertension
preterm PROM ¼ preterm premature rupture of membranes
PVE ¼ periventricular echodensity
PVL ¼ periventricular leukomalacia
SGA ¼ small for gestational age
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cerebral palsy and/or intellectual disability, two and seven
were born to women with and without chronic kidney
disease, respectively. Thus, the posterior probability ofTABLE 3.
Posterior Probability and Highest Probability Density of CP and/or ID in the Children of P
Variables Likelihood n
CP (with CKD) 1/156 20,000
CP (without CKD) 6/3067 20,000
CP and/or ID (with CKD) 2/156 20,000
CP and/or ID (without CKD) 7/3067 20,000
Abbreviations:
CKD ¼ chronic kidney disease
CP ¼ cerebral palsy
ID ¼ intellectual disability
SD ¼ standard deviation
HPD ¼ highest probability densitychildren that are born to women with and without chronic
kidney disease developing cerebral palsy and/or intellectual
disability was found to be 0.01900 and 0.002610, respec-
tively. Consequently, this study revealed that the incidenceregnant Women With and Without CKD
Mean SD 95% HPD Interval
0.012600 0.008910 0.000245-0.029800
0.002280 0.000864 0.000801-0.004050
0.019000 0.010900 0.001940-0.040300
0.002610 0.000923 0.000973-0.004450
F. Tsuchiyama et al. / Pediatric Neurology 73 (2017) 71e77 75of cerebral palsy and/or intellectual disability was 7.2-fold
higher in children born to women with chronic kidney
disease than in those born to women without chronic kid-
ney disease.
The prenatal events and factors that inﬂuence the risk of
cerebral palsy and/or intellectual disability in children born
to women with chronic kidney disease are described in
Table 4. A primiparous mother (OR: 4.07, 95% CI: 2.78 to
5.95), preeclampsia (OR: 6.44, 95% CI: 3.92 to 10.59), grade 1
to 4 IVH (OR: 7.71, 95% CI: 2.05 to 28.92), and an Apgar score
of less than 7 at ﬁve minutes (OR: 0.51, 95% CI: 0.27 to 0.96)
were found to affect the risk of cerebral palsy and/or in-
tellectual disability in such children.Discussion
Several studies have examined the pregnancy outcomes
of womenwith chronic kidney disease. These studies found
that 17% to 60% of cases involved preterm deliveries, 30% to
59% of cases involved Caesarean sections, and preeclampsia
occurred in 13% to 64% of pregnancies.1-6 Fink et al.4 sug-
gested that women with renal disease are at increased risk
of preeclampsia (OR: 7.2, 95% CI: 4.2 to 12.5), preterm labor
(OR: 7.9, 95% CI: 1.9 to 32.6), dysfunctional labor (OR: 3.6,
95% CI: 1.1 to 11.5), and Caesarean section (OR: 3.1, 95% CI:
2.0 to 4.8). Our ﬁndings regarding the maternal outcomes of
pregnant women with chronic kidney disease were
consistent with those of previous case reports, i.e., the in-
cidences of preeclampsia, preterm delivery, and Caesarean
section were 17.9%, 34.6%, and 46.1%, respectively.
Recently, Nevis et al.2 reviewed pregnancies involving
women with kidney disease and revealed that the overall
risk of adverse fetal events was two-fold higher in such
women than in womenwithout kidney disease.2 Alsuwaida
et al.5 also suggested that women with estimated glomer-
ular ﬁltration rate of 60 to 89 mL/min/1.73 m2 are at
signiﬁcantly greater risk of preterm births (31.2%) and of
delivering children that manifest IUGR (38.5%) or intra-
uterine fetal death (15.8%). In studies involving at least 25
pregnancies, the prevalence rates of stillbirths and
neonatal/perinatal deaths ranged from 8% to 15%.18 There
have been several reports about perinatal mortality in
pregnant women with chronic kidney disease1,3,6,18-20;
however, our study was ﬁrst to examine the frequency of
cerebral palsy and/or intellectual disability among the
children born to such women.TABLE 4.
Prenatal Events and the Factors That Inﬂuence the Risk of Cerebral Palsy and/or Intellect
Variables Multiple Regression Analysis
Case (n ¼ 156) Cont
Primipara 116 1885
Preeclampsia 28 90
Grade 1-4 intraventricular
hemorrhaging
4 13
Apgar score <7 at ﬁve min 7 79
Abbreviations:
95% CI ¼ 95% conﬁdence interval
CKD ¼ chronic kidney disease
OR ¼ odds ratio
Data are presented as n values.With regard to the developmental delays experienced by
children born to women with chronic kidney disease, Ker-
stjens et al.21 found that among moderately preterm-born
(between 32 0/7 and 35 6/7 weeks of gestation) children
the incidence of developmental delays was 14.2% higher in
those that were SGA (a proxy for IUGR; SGA: 21.9%, no SGA:
7.7%, P < 0.05, adjusted OR: 2.75, CI: 1.25 to 6.08), 10.5%
higher in cases involving preexisting maternal obesity
(obesity: 18.0%, no obesity: 7.5%, P< 0.01, adjusted OR: 2.73,
CI: 1.35 to 5.52), 4.2% higher in cases involving multiple
pregnancies (multiple: 12.0%, singleton: 7.8%, P < 0.05,
adjusted OR: 1.86, CI: 1.02 to 3.42), and 9.2% higher in males
(males: 13.0%, females: 3.8%, P < 0.001, adjusted OR: 4.20,
CI: 2.09 to 8.46). The abovementioned relationship between
SGA and the risk of developmental delays was in line with
the ﬁndings of other reports about term or early-preterm
children.22,23 Our study also detected an association be-
tween SGA and the risk of cerebral palsy and/or intellectual
disability in the children born to women with chronic kid-
ney disease, although cases involving multiple pregnancies
were excluded, and no association was detected between
the risk of cerebral palsy and/or intellectual disability and
male sex.
Trønnes et al.24 assessed the risk of cerebral palsy in
relation to various pregnancy-related disorders in a study of
all the live births that took place in Norway from 1967
through 2001. In total, 1,764,509 children that were deliv-
ered between 23 and 43 weeks’ gestation were included.24
In the latter study, the prevalence of cerebral palsy was 1.8
per 1000 births, and placental abruption, chorioamnionitis,
PROM, IUGR, preeclampsia, multiple births, placenta previa,
bleeding, cervical conization, and congenital malformations
were all found to be associated with cerebral palsy.24 In our
study, preeclampsia was more common in the pregnant
women with chronic kidney disease (28 of 156 versus 90 of
3067 cases, respectively; P< 0.001). As for other pregnancy-
related disorders, Shatrov et al.25 examined the relationship
between clinical or histologic chorioamnionitis and cerebral
palsy in a meta-analysis. As a result, they detected signiﬁ-
cant associations between clinical chorioamnionitis or his-
tologic chorioamnionitis and cerebral palsy. Speciﬁcally,
pooled OR for cerebral palsy of 2.42 (95% CI: 1.52 to 3.84)
and 1.83 (95% CI: 1.17 to 2.89) were obtained for clinical
chorioamnionitis (chi1 ¼ 13.91; P < 0.001) and histologic
chorioamnionitis (chi1 ¼ 6.86; P ¼ 0.009), respectively.25
These ﬁndings suggest that neonates that are exposed to
clinical chorioamnionitis or histologic chorioamnionitis areual Disability in the Children of Pregnant Women With CKD
rol Group (n ¼ 3,067) OR (95% CI) P Value
4.07 (2.78-5.95) <0.001
6.44 (3.92-10.59) <0.001
7.71 (2.05-28.92) <0.001
0.51 (0.27-0.96) 0.037
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tively.25 However, in our study, none of the pregnant
women with chronic kidney disease had chorioamnionitis,
and thus it was presumed that our study was limited by its
retrospective nature and relatively small sample size.
IVH is the most common type of intracranial hemor-
rhaging observed in preterm neonates, and it has been
demonstrated to be a precursor of poor neurocognitive
development, cerebral palsy, and death.26 Recently, Calisici
et al.26 determined the neurodevelopmental outcomes (at
corrected ages of 18 to 24 months) of 138 preterm infants
who were born prior to 37 weeks’ gestation and had grade
3 to 4 IVH. Although they demonstrated that the long-term
outcomes (at age two years) of preterm infants do not differ
according to birth weight, they concluded that severe IVH is
a signiﬁcant risk factor for poor neurodevelopmental out-
comes in this already high-risk population.26 On the other
hand, Brumbaugh et al.8 found that the rates of neonatal
morbidities and cerebral palsy among preterm neonates
that were delivered by Caesarean section due a non-
reassuring fetal heart rate pattern were not affected by the
presence of grade 3 or 4 IVH. In our study, we revealed that
the frequency of grade 1 to 4 IVH was signiﬁcantly higher
among the pregnant women with chronic kidney disease,
and it was presumed that this was due to the fact that our
study population was not solely composed of infants that
underwent preterm or Caesarean deliveries.
Finally, many studies have revealed that pregnant
women with chronic kidney disease tend to have sicker
infants.1,3,6,18-20 Thus our ﬁnding that neurological disor-
ders, such as cerebral palsy or intellectual disability, are
more common in children born to women with chronic
kidney disease is not surprising. In this study, two of the
children (2 of 156, or 1.28%) born to women with chronic
kidney disease manifested severe neurological damage (one
had IVH, and the other had PVL). These two children were
both born at 28 weeks’ gestation. Preterm birth can increase
a child’s risk of cerebral palsy by up to 100-fold.27 However,
preterm and very preterm births contribute to the devel-
opment of cerebral palsy in fewer than half of the pa-
tients.27 On the other hand, Himpens et al.28 reported that
the prevalence of cerebral palsy decreases signiﬁcantly with
increasing gestational age category: 14.6% at 22 to 27weeks’
gestation, 6.2% at 28 to 31 weeks’ gestation, 0.7% at 32 to
36 weeks’ gestation, and 0.1% in term infants. For this
reason, we speculate that prematurity contributed to the
occurrence of cerebral palsy or intellectual disability in the
children born to womenwith chronic kidney disease in this
study.Limitations of the study
Several limitations should be considered when inter-
preting the results of our study. First, there were several
minor limitations such as the small sample size, which led
to inadequate assessments; the short duration of therapy;
and the fact that the study involved a heterogeneous group
of patients with chronic kidney disease. Second, our data
were collected retrospectively, and so prospective studies
are required to conﬁrm our results.Conclusion
Our study indicated that a primiparous mother, pre-
eclampsia, grade 1 to 4 IVH, and an Apgar score of less than
7 at ﬁve minutes inﬂuence the risk of cerebral palsy and/or
intellectual disability in children born to women with
chronic kidney disease. Moreover, this study revealed that
compared with children born to women without chronic
kidney disease, those born to women with chronic kidney
disease exhibited a 7.2-fold higher incidence rate of cerebral
palsy and/or intellectual disability.
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